Latest Articles
- Widespread skin-thickening and hyperpigmentation
A 37-year-old military veteran presented with extensive velvety hyperpigmented plaques over nearly 15% of the total body surface.
- Diversifying medical humanities: The case for Jay-Z
Physicians carry considerable power in the patient-physician relationship. Opening our minds to the viewpoints of others diffuses some of that power and grounds us in the communities we serve.
- Balancing the myths of corticosteroid therapy
No class of drug has more mythical attributes, interfaces with different medical specialties, or clinical street lore than corticosteroids.
- Hyperpigmentation as a clue to Addison disease
The 66-year-old woman presented with fatigue, loss of appetite, and hyperpigmentation of the tongue, soft palate, buccal mucosa, lower lip, fingers, and nail beds.
- Phenytoin-induced gingival overgrowth
A young man presented with lower-extremity weakness and slurred speech. He has been on seizure prophylaxis after experiencing a seizure following hemicraniectomy for subdural hematoma.
- Primary and secondary prevention of atherosclerotic cardiovascular disease: A case-based approach
The authors present commonly encountered clinical scenarios that pose challenges in decision-making in primary and secondary prevention.
- Xanthomas: Differentiating atherogenic from nonatherogenic
The patient had tendinous xanthomas on the dorsal joints of the hand and eruptive xanthomas on the buttock, as well as xanthoma striatum palmare on the volar aspect of the hand.
- What are the considerations in patient selection and timing of risk-reducing mastectomy?
The option of risk-reducing mastectomy is for those at highest risk, and multidisciplinary conversations setting patient expectations are critical for optimal patient outcomes.
- Do all patients with primary pulmonary coccidioidomycosis need antifungal therapy?
Patients diagnosed with this condition who have no symptoms or are mildly symptomatic do not require treatment and can be closely monitored.
The role of GLP-1 receptor agonists in managing type 2 diabetesA review of the evidence regarding the benefits and adverse effects of GLP-1 receptor agonists in patients with type 2 diabetes mellitus or obesity.
